The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Hepatitis B Vaccination Market Research Report 2025
Synopsis
Hepatitis B vaccine is a vaccine that prevents hepatitis B. The first dose is recommended within 24 hours of birth with either two or three more doses given after that. This includes those with poor immune function such as from HIV/AIDS and those born premature. It is also recommended that health-care workers be vaccinated. In healthy people routine immunization results in more than 95% of people being protected.
The global Hepatitis B Vaccination market was valued at US$ 1063 million in 2023 and is anticipated to reach US$ 1179.8 million by 2030, witnessing a CAGR of 1.5% during the forecast period 2024-2030.
The hepatitis B vaccination market is driven by the increasing focus on disease prevention and the rising awareness of the importance of immunization. Hepatitis B vaccines provide essential protection against the hepatitis B virus (HBV), which can cause chronic liver infections and increase the risk of liver cirrhosis and cancer. The rise in the prevalence of hepatitis B infections and the need for effective control of the disease contribute to market growth as vaccination plays a crucial role in reducing transmission and preventing complications. Moreover, advancements in vaccine technology, such as the development of combination vaccines and birth dose administration, have improved vaccine accessibility and coverage. However, the market also faces challenges, including vaccine supply limitations and the need for ongoing public health initiatives to address barriers to vaccination, such as vaccine hesitancy and lack of awareness. Additionally, ensuring equitable access to hepatitis B vaccines and increasing vaccination rates in high-risk populations can pose obstacles for comprehensive disease prevention. To succeed, companies must focus on research and development to offer innovative and affordable hepatitis B vaccines, collaborate with healthcare providers and governments to implement vaccination programs, and address the challenges to meet the increasing demand for effective and accessible protection against hepatitis B.
This report aims to provide a comprehensive presentation of the global market for Hepatitis B Vaccination, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hepatitis B Vaccination.
Report Scope
The Hepatitis B Vaccination market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hepatitis B Vaccination market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hepatitis B Vaccination manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
NCPC
Merck
Bio Kangtai
Dynavax
Hissen
KM Biologics
LG Life Sciences
Serum Institute
Segment by Type
Yeast Derived
CHO Derived
Segment by Application
Children
Adult
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Hepatitis B Vaccination manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Hepatitis B Vaccination in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Hepatitis B vaccine is a vaccine that prevents hepatitis B. The first dose is recommended within 24 hours of birth with either two or three more doses given after that. This includes those with poor immune function such as from HIV/AIDS and those born premature. It is also recommended that health-care workers be vaccinated. In healthy people routine immunization results in more than 95% of people being protected.
The global Hepatitis B Vaccination market was valued at US$ 1063 million in 2023 and is anticipated to reach US$ 1179.8 million by 2030, witnessing a CAGR of 1.5% during the forecast period 2024-2030.
The hepatitis B vaccination market is driven by the increasing focus on disease prevention and the rising awareness of the importance of immunization. Hepatitis B vaccines provide essential protection against the hepatitis B virus (HBV), which can cause chronic liver infections and increase the risk of liver cirrhosis and cancer. The rise in the prevalence of hepatitis B infections and the need for effective control of the disease contribute to market growth as vaccination plays a crucial role in reducing transmission and preventing complications. Moreover, advancements in vaccine technology, such as the development of combination vaccines and birth dose administration, have improved vaccine accessibility and coverage. However, the market also faces challenges, including vaccine supply limitations and the need for ongoing public health initiatives to address barriers to vaccination, such as vaccine hesitancy and lack of awareness. Additionally, ensuring equitable access to hepatitis B vaccines and increasing vaccination rates in high-risk populations can pose obstacles for comprehensive disease prevention. To succeed, companies must focus on research and development to offer innovative and affordable hepatitis B vaccines, collaborate with healthcare providers and governments to implement vaccination programs, and address the challenges to meet the increasing demand for effective and accessible protection against hepatitis B.
This report aims to provide a comprehensive presentation of the global market for Hepatitis B Vaccination, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hepatitis B Vaccination.
Report Scope
The Hepatitis B Vaccination market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hepatitis B Vaccination market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hepatitis B Vaccination manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
NCPC
Merck
Bio Kangtai
Dynavax
Hissen
KM Biologics
LG Life Sciences
Serum Institute
Segment by Type
Yeast Derived
CHO Derived
Segment by Application
Children
Adult
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Hepatitis B Vaccination manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Hepatitis B Vaccination in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Hepatitis B Vaccination Market Overview
1.1 Product Overview and Scope of Hepatitis B Vaccination
1.2 Hepatitis B Vaccination Segment by Type
1.2.1 Global Hepatitis B Vaccination Market Value Comparison by Type (2024-2030)
1.2.2 Yeast Derived
1.2.3 CHO Derived
1.3 Hepatitis B Vaccination Segment by Application
1.3.1 Global Hepatitis B Vaccination Market Value by Application: (2024-2030)
1.3.2 Children
1.3.3 Adult
1.4 Global Hepatitis B Vaccination Market Size Estimates and Forecasts
1.4.1 Global Hepatitis B Vaccination Revenue 2019-2030
1.4.2 Global Hepatitis B Vaccination Sales 2019-2030
1.4.3 Global Hepatitis B Vaccination Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Hepatitis B Vaccination Market Competition by Manufacturers
2.1 Global Hepatitis B Vaccination Sales Market Share by Manufacturers (2019-2024)
2.2 Global Hepatitis B Vaccination Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Hepatitis B Vaccination Average Price by Manufacturers (2019-2024)
2.4 Global Hepatitis B Vaccination Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Hepatitis B Vaccination, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Hepatitis B Vaccination, Product Type & Application
2.7 Hepatitis B Vaccination Market Competitive Situation and Trends
2.7.1 Hepatitis B Vaccination Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Hepatitis B Vaccination Players Market Share by Revenue
2.7.3 Global Hepatitis B Vaccination Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Hepatitis B Vaccination Retrospective Market Scenario by Region
3.1 Global Hepatitis B Vaccination Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Hepatitis B Vaccination Global Hepatitis B Vaccination Sales by Region: 2019-2030
3.2.1 Global Hepatitis B Vaccination Sales by Region: 2019-2024
3.2.2 Global Hepatitis B Vaccination Sales by Region: 2025-2030
3.3 Global Hepatitis B Vaccination Global Hepatitis B Vaccination Revenue by Region: 2019-2030
3.3.1 Global Hepatitis B Vaccination Revenue by Region: 2019-2024
3.3.2 Global Hepatitis B Vaccination Revenue by Region: 2025-2030
3.4 North America Hepatitis B Vaccination Market Facts & Figures by Country
3.4.1 North America Hepatitis B Vaccination Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Hepatitis B Vaccination Sales by Country (2019-2030)
3.4.3 North America Hepatitis B Vaccination Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Hepatitis B Vaccination Market Facts & Figures by Country
3.5.1 Europe Hepatitis B Vaccination Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Hepatitis B Vaccination Sales by Country (2019-2030)
3.5.3 Europe Hepatitis B Vaccination Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hepatitis B Vaccination Market Facts & Figures by Country
3.6.1 Asia Pacific Hepatitis B Vaccination Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Hepatitis B Vaccination Sales by Country (2019-2030)
3.6.3 Asia Pacific Hepatitis B Vaccination Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Hepatitis B Vaccination Market Facts & Figures by Country
3.7.1 Latin America Hepatitis B Vaccination Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Hepatitis B Vaccination Sales by Country (2019-2030)
3.7.3 Latin America Hepatitis B Vaccination Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Hepatitis B Vaccination Market Facts & Figures by Country
3.8.1 Middle East and Africa Hepatitis B Vaccination Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Hepatitis B Vaccination Sales by Country (2019-2030)
3.8.3 Middle East and Africa Hepatitis B Vaccination Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Hepatitis B Vaccination Sales by Type (2019-2030)
4.1.1 Global Hepatitis B Vaccination Sales by Type (2019-2024)
4.1.2 Global Hepatitis B Vaccination Sales by Type (2025-2030)
4.1.3 Global Hepatitis B Vaccination Sales Market Share by Type (2019-2030)
4.2 Global Hepatitis B Vaccination Revenue by Type (2019-2030)
4.2.1 Global Hepatitis B Vaccination Revenue by Type (2019-2024)
4.2.2 Global Hepatitis B Vaccination Revenue by Type (2025-2030)
4.2.3 Global Hepatitis B Vaccination Revenue Market Share by Type (2019-2030)
4.3 Global Hepatitis B Vaccination Price by Type (2019-2030)
5 Segment by Application
5.1 Global Hepatitis B Vaccination Sales by Application (2019-2030)
5.1.1 Global Hepatitis B Vaccination Sales by Application (2019-2024)
5.1.2 Global Hepatitis B Vaccination Sales by Application (2025-2030)
5.1.3 Global Hepatitis B Vaccination Sales Market Share by Application (2019-2030)
5.2 Global Hepatitis B Vaccination Revenue by Application (2019-2030)
5.2.1 Global Hepatitis B Vaccination Revenue by Application (2019-2024)
5.2.2 Global Hepatitis B Vaccination Revenue by Application (2025-2030)
5.2.3 Global Hepatitis B Vaccination Revenue Market Share by Application (2019-2030)
5.3 Global Hepatitis B Vaccination Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Hepatitis B Vaccination Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GSK Hepatitis B Vaccination Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 NCPC
6.2.1 NCPC Corporation Information
6.2.2 NCPC Description and Business Overview
6.2.3 NCPC Hepatitis B Vaccination Sales, Revenue and Gross Margin (2019-2024)
6.2.4 NCPC Hepatitis B Vaccination Product Portfolio
6.2.5 NCPC Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Hepatitis B Vaccination Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merck Hepatitis B Vaccination Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Bio Kangtai
6.4.1 Bio Kangtai Corporation Information
6.4.2 Bio Kangtai Description and Business Overview
6.4.3 Bio Kangtai Hepatitis B Vaccination Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Bio Kangtai Hepatitis B Vaccination Product Portfolio
6.4.5 Bio Kangtai Recent Developments/Updates
6.5 Dynavax
6.5.1 Dynavax Corporation Information
6.5.2 Dynavax Description and Business Overview
6.5.3 Dynavax Hepatitis B Vaccination Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Dynavax Hepatitis B Vaccination Product Portfolio
6.5.5 Dynavax Recent Developments/Updates
6.6 Hissen
6.6.1 Hissen Corporation Information
6.6.2 Hissen Description and Business Overview
6.6.3 Hissen Hepatitis B Vaccination Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Hissen Hepatitis B Vaccination Product Portfolio
6.6.5 Hissen Recent Developments/Updates
6.7 KM Biologics
6.6.1 KM Biologics Corporation Information
6.6.2 KM Biologics Description and Business Overview
6.6.3 KM Biologics Hepatitis B Vaccination Sales, Revenue and Gross Margin (2019-2024)
6.4.4 KM Biologics Hepatitis B Vaccination Product Portfolio
6.7.5 KM Biologics Recent Developments/Updates
6.8 LG Life Sciences
6.8.1 LG Life Sciences Corporation Information
6.8.2 LG Life Sciences Description and Business Overview
6.8.3 LG Life Sciences Hepatitis B Vaccination Sales, Revenue and Gross Margin (2019-2024)
6.8.4 LG Life Sciences Hepatitis B Vaccination Product Portfolio
6.8.5 LG Life Sciences Recent Developments/Updates
6.9 Serum Institute
6.9.1 Serum Institute Corporation Information
6.9.2 Serum Institute Description and Business Overview
6.9.3 Serum Institute Hepatitis B Vaccination Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Serum Institute Hepatitis B Vaccination Product Portfolio
6.9.5 Serum Institute Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hepatitis B Vaccination Industry Chain Analysis
7.2 Hepatitis B Vaccination Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hepatitis B Vaccination Production Mode & Process
7.4 Hepatitis B Vaccination Sales and Marketing
7.4.1 Hepatitis B Vaccination Sales Channels
7.4.2 Hepatitis B Vaccination Distributors
7.5 Hepatitis B Vaccination Customers
8 Hepatitis B Vaccination Market Dynamics
8.1 Hepatitis B Vaccination Industry Trends
8.2 Hepatitis B Vaccination Market Drivers
8.3 Hepatitis B Vaccination Market Challenges
8.4 Hepatitis B Vaccination Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Hepatitis B Vaccination Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Hepatitis B Vaccination Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Hepatitis B Vaccination Market Competitive Situation by Manufacturers in 2023
Table 4. Global Hepatitis B Vaccination Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Hepatitis B Vaccination Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Hepatitis B Vaccination Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Hepatitis B Vaccination Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Hepatitis B Vaccination Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Hepatitis B Vaccination, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Hepatitis B Vaccination, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Hepatitis B Vaccination, Product Type & Application
Table 12. Global Key Manufacturers of Hepatitis B Vaccination, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Hepatitis B Vaccination by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis B Vaccination as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Hepatitis B Vaccination Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Hepatitis B Vaccination Sales by Region (2019-2024) & (K Units)
Table 18. Global Hepatitis B Vaccination Sales Market Share by Region (2019-2024)
Table 19. Global Hepatitis B Vaccination Sales by Region (2025-2030) & (K Units)
Table 20. Global Hepatitis B Vaccination Sales Market Share by Region (2025-2030)
Table 21. Global Hepatitis B Vaccination Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Hepatitis B Vaccination Revenue Market Share by Region (2019-2024)
Table 23. Global Hepatitis B Vaccination Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Hepatitis B Vaccination Revenue Market Share by Region (2025-2030)
Table 25. North America Hepatitis B Vaccination Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Hepatitis B Vaccination Sales by Country (2019-2024) & (K Units)
Table 27. North America Hepatitis B Vaccination Sales by Country (2025-2030) & (K Units)
Table 28. North America Hepatitis B Vaccination Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Hepatitis B Vaccination Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Hepatitis B Vaccination Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Hepatitis B Vaccination Sales by Country (2019-2024) & (K Units)
Table 32. Europe Hepatitis B Vaccination Sales by Country (2025-2030) & (K Units)
Table 33. Europe Hepatitis B Vaccination Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Hepatitis B Vaccination Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Hepatitis B Vaccination Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Hepatitis B Vaccination Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Hepatitis B Vaccination Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Hepatitis B Vaccination Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Hepatitis B Vaccination Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Hepatitis B Vaccination Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Hepatitis B Vaccination Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Hepatitis B Vaccination Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Hepatitis B Vaccination Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Hepatitis B Vaccination Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Hepatitis B Vaccination Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Hepatitis B Vaccination Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Hepatitis B Vaccination Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Hepatitis B Vaccination Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Hepatitis B Vaccination Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Hepatitis B Vaccination Sales (K Units) by Type (2019-2024)
Table 51. Global Hepatitis B Vaccination Sales (K Units) by Type (2025-2030)
Table 52. Global Hepatitis B Vaccination Sales Market Share by Type (2019-2024)
Table 53. Global Hepatitis B Vaccination Sales Market Share by Type (2025-2030)
Table 54. Global Hepatitis B Vaccination Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Hepatitis B Vaccination Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Hepatitis B Vaccination Revenue Market Share by Type (2019-2024)
Table 57. Global Hepatitis B Vaccination Revenue Market Share by Type (2025-2030)
Table 58. Global Hepatitis B Vaccination Price (US$/Unit) by Type (2019-2024)
Table 59. Global Hepatitis B Vaccination Price (US$/Unit) by Type (2025-2030)
Table 60. Global Hepatitis B Vaccination Sales (K Units) by Application (2019-2024)
Table 61. Global Hepatitis B Vaccination Sales (K Units) by Application (2025-2030)
Table 62. Global Hepatitis B Vaccination Sales Market Share by Application (2019-2024)
Table 63. Global Hepatitis B Vaccination Sales Market Share by Application (2025-2030)
Table 64. Global Hepatitis B Vaccination Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Hepatitis B Vaccination Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Hepatitis B Vaccination Revenue Market Share by Application (2019-2024)
Table 67. Global Hepatitis B Vaccination Revenue Market Share by Application (2025-2030)
Table 68. Global Hepatitis B Vaccination Price (US$/Unit) by Application (2019-2024)
Table 69. Global Hepatitis B Vaccination Price (US$/Unit) by Application (2025-2030)
Table 70. GSK Corporation Information
Table 71. GSK Description and Business Overview
Table 72. GSK Hepatitis B Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. GSK Hepatitis B Vaccination Product
Table 74. GSK Recent Developments/Updates
Table 75. NCPC Corporation Information
Table 76. NCPC Description and Business Overview
Table 77. NCPC Hepatitis B Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. NCPC Hepatitis B Vaccination Product
Table 79. NCPC Recent Developments/Updates
Table 80. Merck Corporation Information
Table 81. Merck Description and Business Overview
Table 82. Merck Hepatitis B Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Merck Hepatitis B Vaccination Product
Table 84. Merck Recent Developments/Updates
Table 85. Bio Kangtai Corporation Information
Table 86. Bio Kangtai Description and Business Overview
Table 87. Bio Kangtai Hepatitis B Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Bio Kangtai Hepatitis B Vaccination Product
Table 89. Bio Kangtai Recent Developments/Updates
Table 90. Dynavax Corporation Information
Table 91. Dynavax Description and Business Overview
Table 92. Dynavax Hepatitis B Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Dynavax Hepatitis B Vaccination Product
Table 94. Dynavax Recent Developments/Updates
Table 95. Hissen Corporation Information
Table 96. Hissen Description and Business Overview
Table 97. Hissen Hepatitis B Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Hissen Hepatitis B Vaccination Product
Table 99. Hissen Recent Developments/Updates
Table 100. KM Biologics Corporation Information
Table 101. KM Biologics Description and Business Overview
Table 102. KM Biologics Hepatitis B Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. KM Biologics Hepatitis B Vaccination Product
Table 104. KM Biologics Recent Developments/Updates
Table 105. LG Life Sciences Corporation Information
Table 106. LG Life Sciences Description and Business Overview
Table 107. LG Life Sciences Hepatitis B Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. LG Life Sciences Hepatitis B Vaccination Product
Table 109. LG Life Sciences Recent Developments/Updates
Table 110. Serum Institute Corporation Information
Table 111. Serum Institute Description and Business Overview
Table 112. Serum Institute Hepatitis B Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Serum Institute Hepatitis B Vaccination Product
Table 114. Serum Institute Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Hepatitis B Vaccination Distributors List
Table 118. Hepatitis B Vaccination Customers List
Table 119. Hepatitis B Vaccination Market Trends
Table 120. Hepatitis B Vaccination Market Drivers
Table 121. Hepatitis B Vaccination Market Challenges
Table 122. Hepatitis B Vaccination Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Hepatitis B Vaccination
Figure 2. Global Hepatitis B Vaccination Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Hepatitis B Vaccination Market Share by Type in 2023 & 2030
Figure 4. Yeast Derived Product Picture
Figure 5. CHO Derived Product Picture
Figure 6. Global Hepatitis B Vaccination Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Hepatitis B Vaccination Market Share by Application in 2023 & 2030
Figure 8. Children
Figure 9. Adult
Figure 10. Global Hepatitis B Vaccination Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Hepatitis B Vaccination Market Size (2019-2030) & (US$ Million)
Figure 12. Global Hepatitis B Vaccination Sales (2019-2030) & (K Units)
Figure 13. Global Hepatitis B Vaccination Average Price (US$/Unit) & (2019-2030)
Figure 14. Hepatitis B Vaccination Report Years Considered
Figure 15. Hepatitis B Vaccination Sales Share by Manufacturers in 2023
Figure 16. Global Hepatitis B Vaccination Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Hepatitis B Vaccination Players: Market Share by Revenue in 2023
Figure 18. Hepatitis B Vaccination Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Hepatitis B Vaccination Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Hepatitis B Vaccination Sales Market Share by Country (2019-2030)
Figure 21. North America Hepatitis B Vaccination Revenue Market Share by Country (2019-2030)
Figure 22. United States Hepatitis B Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Hepatitis B Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Hepatitis B Vaccination Sales Market Share by Country (2019-2030)
Figure 25. Europe Hepatitis B Vaccination Revenue Market Share by Country (2019-2030)
Figure 26. Germany Hepatitis B Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Hepatitis B Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Hepatitis B Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Hepatitis B Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia Hepatitis B Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Hepatitis B Vaccination Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Hepatitis B Vaccination Revenue Market Share by Region (2019-2030)
Figure 33. China Hepatitis B Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Hepatitis B Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Hepatitis B Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Hepatitis B Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia Hepatitis B Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. China Taiwan Hepatitis B Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Indonesia Hepatitis B Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Thailand Hepatitis B Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Malaysia Hepatitis B Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Latin America Hepatitis B Vaccination Sales Market Share by Country (2019-2030)
Figure 43. Latin America Hepatitis B Vaccination Revenue Market Share by Country (2019-2030)
Figure 44. Mexico Hepatitis B Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Brazil Hepatitis B Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Argentina Hepatitis B Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Hepatitis B Vaccination Sales Market Share by Country (2019-2030)
Figure 48. Middle East & Africa Hepatitis B Vaccination Revenue Market Share by Country (2019-2030)
Figure 49. Turkey Hepatitis B Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Hepatitis B Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. UAE Hepatitis B Vaccination Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Global Sales Market Share of Hepatitis B Vaccination by Type (2019-2030)
Figure 53. Global Revenue Market Share of Hepatitis B Vaccination by Type (2019-2030)
Figure 54. Global Hepatitis B Vaccination Price (US$/Unit) by Type (2019-2030)
Figure 55. Global Sales Market Share of Hepatitis B Vaccination by Application (2019-2030)
Figure 56. Global Revenue Market Share of Hepatitis B Vaccination by Application (2019-2030)
Figure 57. Global Hepatitis B Vaccination Price (US$/Unit) by Application (2019-2030)
Figure 58. Hepatitis B Vaccination Value Chain
Figure 59. Hepatitis B Vaccination Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
